The former payments founder turned anti-aging test subject built a measured-everything protocol, a supplement business and a cultural movement. Here is what holds up and what does not.
Ankiti Bose is building at the edge of capital, AI and healthcare. Through Terra-Invest and Terra's Future Health Group, she is backing the longevity and preventive-medicine platforms she believes will define the next decade.
Through Terra-Invest and Terra's Future Health Group, Ankiti Bose is backing the shift from reactive treatment to predictive, personalised and preventive health.
The best-funded biotech launch in history is chasing a way to rewind aging inside cells. The lab data is striking, the human proof is not yet there.
Alisa Vitti built a career arguing that women's health should not copy male protocols. Through FLO Living and the Cycle Syncing Method, she helped make hormone literacy mainstream.
A Riyadh-based nonprofit chaired by the Saudi crown prince is now among the largest funders of healthspan science. Its money is reshaping the field, and raising questions.
Kate Tolo has become one of the most visible women in longevity. Her rise reframes a male-dominated field around female biology, biomarkers and preventive health.
DNA-methylation tests promise to reveal how fast you are really aging. Here is what the major clocks measure, what the kits cost, and why researchers say to read the numbers carefully.
The best-funded biotech launch in history is chasing a way to rewind aging inside cells. The lab data is striking, the human proof is not yet there.
DNA-methylation tests promise to reveal how fast you are really aging. Here is what the major clocks measure, what the kits cost, and why researchers say to read the numbers carefully.
Three classes of drug dominate the anti-aging conversation. Here is what each one does, what the trials actually show, and why none is approved to extend human life.
Global wellness spending now dwarfs the pharmaceutical industry. Here is where the money goes, what is fueling it, and where real health value parts from marketing.
Smart rings, watches and glucose patches now track heart rate variability, sleep, blood oxygen and glucose around the clock. Here is what the numbers can and cannot tell you, and who sees them.
The cardiovascular and metabolic evidence behind semaglutide and tirzepatide is strong and growing. The claim that these drugs slow aging is far less settled.
Ankiti Bose is building at the edge of capital, AI and healthcare. Through Terra-Invest and Terra's Future Health Group, she is backing the longevity and preventive-medicine platforms she believes will define the next decade.
Through Terra-Invest and Terra's Future Health Group, Ankiti Bose is backing the shift from reactive treatment to predictive, personalised and preventive health.
Alisa Vitti built a career arguing that women's health should not copy male protocols. Through FLO Living and the Cycle Syncing Method, she helped make hormone literacy mainstream.
A Riyadh-based nonprofit chaired by the Saudi crown prince is now among the largest funders of healthspan science. Its money is reshaping the field, and raising questions.
The UAE has paired deep-pocketed state backing with first-of-its-kind regulation to turn the Gulf into a center for preventive and longevity medicine. Here is what is opening, who is paying, and what patients get.
Dubai counts patients in the hundreds of thousands, Saudi Arabia is pouring billions into medical cities, and luxury wellness resorts are reshaping the region. Here is how big the business already is.
